February 2010 Infectious Disease

Finding the Right Treatment for Managing Your Acne

February 18, 2010

Patient Education

Patients should understand how to use OTC and prescription medications that treat acne and follow preventive measures to reduce acne flare-ups or prevent this common dermatologic condition.

Rx Product News Profile: A Closer Look at New FDA Actions: Centocor Ortho Biotech's Stelara

February 16, 2010

Rx Product News Profile

The FDA recently approved Centocor Ortho Biotech's Stelara (ustekinumab)for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

The Antibiotic Minimalist: The Patient as Partner

February 16, 2010

Rx Focus

Alternative treatments are available for fighting common viral infections-patients who are educated about these options can overcome the infection without antibiotics. Pharmacists can provide education and join local or national campaigns to help patients avoid antibiotic misuse.

Specialty Pharmaceuticals: Therapy Class Review: Hepatitis C Treatment Guidelines

February 16, 2010

Rx Focus

The pharmacist plays an important role in the pharmaceutical care of patients undergoing treatment for hepatitis C virus (HCV). The new American Association for the Study of Liver Diseases Practice Guidelines are a wealth of information about HCV and provide an invaluable foundation for the care of these patients.

Pharmacy Law: Three-Year Delay in Medicaid Suspension Appealed

February 15, 2010

Legal Focus

A pharmacist appealed a decision of the federal government, which was delayed by nearly 3 years, in imposing and order of exclusion in participating in health care programs receiving federal funding.

Drug Diversion and Abuse: Pseudoephedrine Tracking System-NPLEx

February 15, 2010

Legal Focus

Although restrictions on the sale of pseudoephedrine products have been in place for several years, diversion of these products still occurs-a new electronic tracking system holds the promise to help curb this crime.

Rigorous Standards for Bioequivalence

February 15, 2010

GPhA's Message

Although questions have been raised regarding the safety and efficacy of generic drugs, compared with their brand drug counterparts, the FDA supports the bioequivalence of generic drugs and is helping to deliver important information to patients.

Counseling Patients with the Difficult Diagnosis of Hepatitis C

February 15, 2010

Patient Counseling

Hepatitis C can be a challenging disease for patients. Pharmacists can be instrumental in educating their patients about the pharmacologic agents available for treatment and provide them with valuable resources to successfully manage this condition.